Clinical depression is a major health issue, yet the scale of its impact can still feel surprising even to people who think they know it well. Globally, depressive disorders accounted for 193.8 million DALYs in 2021, and 700,000 people die by suicide each year. In this post, we line up prevalence, disability, comorbid risks like heart disease and diabetes, treatment gaps, and costs to show how depression affects lives in ways that statistics can make sharply visible.
Key Takeaways
- In adults, the prevalence of depression is about 5% in many high-income settings (WHO estimate)
- In the U.S., 8.0% of Hispanic adults had depression in 2022
- The 12-month prevalence of depression in the general population is about 7.2%
- More than 700,000 people die by suicide each year globally
- Depression accounts for about 4.3% of the global Disability-Adjusted Life Years (DALYs)
- In 2019, depression contributed 40.5 million years lived with disability (YLDs) globally
- In the Global Burden of Disease study, depressive disorders accounted for 193.8 million DALYs in 2021
- Major depressive disorder is the leading cause of disability worldwide, accounting for 12% of all disability
- In 2017, depression and anxiety disorders together were estimated to be responsible for 40% of all years lived with disability from mental disorders
- In 2021, 59.2% of U.S. adults with current depression used mental health services in the past year
- In the U.S., 50.2% of adults with depression reported using at least one prescription medication
- In 2019, the median time to mental health treatment in the U.S. was 11 days for antidepressant initiation after an initial diagnosis
- $326 billion annual economic burden of depression in the U.S. (medical costs and lost earnings) in 2013
- $210.5 billion total cost of depression in the EU in 2010 (direct healthcare costs and indirect costs)
- Major depressive disorder costs Australia about AUD $11.6 billion per year (in 2011/12 values)
Depression is widespread and disabling worldwide, affecting millions, increasing chronic disease risk, and driving large costs.
Related reading
01 · Category
Demographics & Subgroups6 stats
01
In adults, the prevalence of depression is about 5% in many high-income settings (WHO estimate)https://www.who.int/news-room/fact-sheets/detail/depression
02
In the U.S., 8.0% of Hispanic adults had depression in 2022https://www.cdc.gov/nchs/fastats/depression.htm
03
The 12-month prevalence of depression in the general population is about 7.2%https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726034/
04
Lifetime prevalence of depression was 23% for women and 11% for men in a large meta-analysishttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3715009/
05
In a large cohort study, depression prevalence increased during COVID-19, peaking at about 25% among certain populations in 2020https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938671/
06
In adolescents, the global prevalence of depressive disorder symptoms was about 13.4% (2020 systematic review estimate)https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312952/
Interpretation
Demographics & Subgroups Interpretation
Across key demographics, depression appears to vary dramatically by group, from about 5% in many high-income settings to roughly 25% in some populations during the COVID-19 peak and lifetime prevalence reaching 23% for women versus 11% for men, with adolescents showing depressive symptoms around 13.4% globally.
02 · Category
Global Prevalence3 stats
01
More than 700,000 people die by suicide each year globallyhttps://www.who.int/news-room/fact-sheets/detail/suicide
02
Depression accounts for about 4.3% of the global Disability-Adjusted Life Years (DALYs)https://vizhub.healthdata.org/gbd-compare/
03
In 2019, depression contributed 40.5 million years lived with disability (YLDs) globallyhttps://ghdx.healthdata.org/gbd-results-tool
Interpretation
Global Prevalence Interpretation
From a global prevalence standpoint, depression is a widespread condition that accounts for about 4.3% of all Disability Adjusted Life Years and 40.5 million years lived with disability in 2019, while the scale of the impact is underscored by more than 700,000 deaths by suicide each year worldwide.
03 · Category
Risk & Burden8 stats
01
In the Global Burden of Disease study, depressive disorders accounted for 193.8 million DALYs in 2021https://vizhub.healthdata.org/gbd-results/
02
Major depressive disorder is the leading cause of disability worldwide, accounting for 12% of all disabilityhttps://www.who.int/health-topics/mental-health
03
In 2017, depression and anxiety disorders together were estimated to be responsible for 40% of all years lived with disability from mental disordershttps://ourworldindata.org/mental-health
04
Depression is associated with an increased risk of cardiovascular disease; a meta-analysis found a higher risk of incident coronary heart disease among people with depression (pooled risk ratio 1.36)https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961489/
05
A meta-analysis found depression is associated with an increased risk of stroke (pooled hazard ratio 1.33)https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855213/
06
In a systematic review, depression was associated with a 45% higher risk of developing type 2 diabetes (pooled relative risk 1.45)https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647161/
07
In a 2012 meta-analysis, people with depression had a 2.0x higher risk of mortality compared with those without depression (pooled hazard ratio 2.0)https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399415/
08
In a large U.S. study, adults with depression reported 1.7 times more work impairment than those without depression (work impairment rate ratio 1.7)https://jamanetwork.com/journals/jama/fullarticle/189089
Interpretation
Risk & Burden Interpretation
Depressive disorders create a major Risk and Burden worldwide, driving 193.8 million DALYs in 2021 and leading to outsized real world health and functioning impacts, from 12% of global disability and 40% of years lived with disability from mental disorders to higher risks of coronary heart disease with a pooled risk ratio of 1.36, stroke with a pooled hazard ratio of 1.33, and type 2 diabetes with a pooled relative risk of 1.45.
More related reading
04 · Category
Treatment & Care8 stats
01
In 2021, 59.2% of U.S. adults with current depression used mental health services in the past yearhttps://www.samhsa.gov/data/report/national-survey-drug-use-and-health-nsduh
02
In the U.S., 50.2% of adults with depression reported using at least one prescription medicationhttps://www.cdc.gov/nchs/nhis.htm
03
In 2019, the median time to mental health treatment in the U.S. was 11 days for antidepressant initiation after an initial diagnosishttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7070898/
04
In a network meta-analysis of antidepressant effectiveness, the probability of response for typical first-line antidepressants is around 50% relative to placebohttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071446/
05
In a landmark trial of collaborative care, patients achieved clinically meaningful improvements with an absolute reduction in depressive symptoms measured by the PHQ-9 of about 5 points over 12 monthshttps://jamanetwork.com/journals/jama/article-abstract/178674
06
In a systematic review, antidepressant treatment for major depression increased remission rates compared with placebo by about 10 percentage pointshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140154/
07
In the U.K., 15% of adults with depression receive no treatmenthttps://www.nice.org.uk/guidance/cg90/evidence/depression-patient-journey-and-service-use
08
In a European primary care study, about 60% of patients with depression were treated with antidepressantshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3969532/
Interpretation
Treatment & Care Interpretation
Across Treatment and Care for clinical depression, many people do not receive timely help, with only 59.2% using mental health services in the prior year and a median of 11 days to start antidepressants, while even when treatments are used typical response rates hover around 50% and remission improves by about 10 percentage points over placebo.
05 · Category
Economic Impact8 stats
01
$326 billion annual economic burden of depression in the U.S. (medical costs and lost earnings) in 2013https://jamanetwork.com/journals/jama/fullarticle/2662691
02
$210.5 billion total cost of depression in the EU in 2010 (direct healthcare costs and indirect costs)https://www.oecd.org/health/health-systems/46816258.pdf
03
Major depressive disorder costs Australia about AUD $11.6 billion per year (in 2011/12 values)https://www.aihw.gov.au/reports/mental-health-services/impact-of-mental-ill-health-on-the-australian-economy/contents/table-of-contents
04
In a U.S. claims study, patients with depression had 2.1x higher annual healthcare expenditures than matched controlshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302816/
05
A 2019 study estimated the global economic burden of depression at US$ 1 trillion per yearhttps://www.sciencedirect.com/science/article/pii/S2215036619300176
06
Depression increases healthcare utilization; in a U.S. cohort, total healthcare cost differences were about $3,000per patient-year versus non-depressed controlshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194317/
07
In a Canadian analysis, the estimated annual economic burden of depression in 2009 was CAD $7.0 billionhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3536008/
08
In a systematic review, depression is associated with increased absenteeism by about 1.3 days per monthhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926445/
Interpretation
Economic Impact Interpretation
Across countries, depression creates a massive economic burden that reaches into the trillions, including an estimated US$1 trillion per year globally and up to US$326 billion annually in the US, alongside clear cost impacts like 2.1 times higher healthcare spending and roughly $3,000 more per patient-year for depressed individuals.
06 · Category
Industry & Services7 stats
01
In 2021, the U.S. mental health services sector employed 1.3 million peoplehttps://www.bls.gov/oes/current/naics/6213.htm
02
The global digital therapeutics market for mental health is forecast to reach $5.1 billion by 2028https://www.grandviewresearch.com/industry-analysis/digital-therapeutics-market
03
In a 2020 meta-analysis, online CBT reduced depressive symptoms with a standardized mean difference of −0.56 compared with control groupshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452532/
04
In the U.S. Medicare population, antidepressant use increased from 2006 to 2018 by about 20%https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2750149
05
In 2022, U.S. emergency department visits with depression-related diagnoses were 3.6 millionhttps://www.hcup-us.ahrq.gov/faststats/depression.jsp
06
In the WHO Mental Health Atlas 2020, 82% of countries reported having a mental health policy or planhttps://www.who.int/publications/i/item/9789240036703
07
In the World Mental Health Survey Initiative, median age of onset for mood disorders is 20 yearshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684369/
Interpretation
Industry & Services Interpretation
In the Industry and Services landscape, mental health demand is clearly scaling, with US emergency department visits tied to depression reaching 3.6 million in 2022 and antidepressant use in the Medicare population rising about 20% from 2006 to 2018.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Timothy Grant. (2026, February 13). Clinical Depression Statistics. Gitnux. https://gitnux.org/clinical-depression-statistics
MLA
Timothy Grant. "Clinical Depression Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/clinical-depression-statistics.
Chicago
Timothy Grant. 2026. "Clinical Depression Statistics." Gitnux. https://gitnux.org/clinical-depression-statistics.
Sources & references
40 datasets cited across this report
+25 additional datasets cited (not shown individually)